迪瑞医疗收盘下跌3.55%，滚动市盈率107.63倍，总市值38.53亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Dirui Medical, indicating a significant decline in revenue and profit for the first quarter of 2025 compared to the previous year [1][2] - Dirui Medical's closing stock price is 14.13 yuan, with a decline of 3.55%, resulting in a rolling PE ratio of 107.63 times, which is significantly higher than the industry average of 53.52 times and the median of 37.14 times [1][2] - The company has a total market capitalization of 3.853 billion yuan, ranking 105th in the medical device industry based on PE ratio [1][2] Group 2 - As of March 31, 2025, Dirui Medical has 17,877 shareholders, a decrease of 209 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The main business of Dirui Medical includes the research, production, marketing, and service of medical testing instruments and related reagents, with key products in various analysis areas [1] - The company holds 213 patents, including 136 invention patents and 96 software copyrights [1] Group 3 - In the latest quarterly report for Q1 2025, Dirui Medical reported an operating income of 182 million yuan, a year-on-year decrease of 72.47%, and a net profit of 15.6787 million yuan, down 87.13%, with a gross profit margin of 42.78% [1]